(USD) | Dec 2023 | Q/Q |
---|---|---|
Revenue | 83.8MM | - |
Gross Profit | 83.5MM | - |
Cost Of Revenue | 260K | -14% |
Operating Income | -4.2MM | -91% |
Operating Expenses | 87.7MM | - |
Net Income | -48.6MM | -25% |
R&D | 66.7MM | +30% |
G&A | 21.2MM | +12% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
LEXINGTON, Mass., April 12, 2024--Agenus Inc. (NASDAQ: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced updated results from its Phase 1 clinical trial of BOT/BAL combination therapy in patients with metastatic CRC that is not microsatellite instability-high (MSS) or deficient mismatch repair (dMMR). These findings build upon the compelling clinical activity demonstrated by BOT/BAL across nine different cancer types in Agenus' bro
Wall Street analysts who watch the cancer drug developer closely think it could rocket higher.
LEXINGTON, Mass., April 05, 2024--Agenus Inc. (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced its stockholders have approved a one-for-twenty reverse stock split of its issued and outstanding common stock, which will go into effect at 12:01 a.m., Eastern Time on April 12, 2024. The reverse stock split is intended to give Agenus greater flexibility in its future financing needs and to increase the per share trading price
These stocks could rocket higher, but they also present significant risks.
Here’s the deal with stocks to turn $1,000 into $1 million: if you want to play, you gotta pay. I’m not just talking about the price of the securities themselves. Indeed, these lesser-known enterprises are relatively low priced. No, the cost comes in the fact that extreme speculation such as this involves an inverse relationship. For maximum potential upside, you typically need to absorb the minimal amount of predictability. Let’s consider blue-chip stocks. Generally, you can be profitable with
There's been a notable change in appetite for Agenus Inc. ( NASDAQ:AGEN ) shares in the week since its yearly report...
Agenus Inc. (NASDAQ:AGEN) Q4 2023 Earnings Call Transcript March 14, 2024 Agenus Inc. misses on earnings expectations. Reported EPS is $-0.13 EPS, expectations were $-0.053. AGEN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name is Audra, […]
The latest analyst coverage could presage a bad day for Agenus Inc. ( NASDAQ:AGEN ), with the analysts making...
AGEN earnings call for the period ending December 31, 2023.
Fast Track Designation for BOT/BAL in Colorectal Cancer and $25 Million Milestone Payment Highlight Progress